VistaGen Therapeutics Inc Shares Near 52-Week Low - Market Mover
The shares closed 0.7% above its 52-week low of $1.53, with trading volume lower than its 30 day average
Jan 21, 2022 by Kwhen Finance Editors
VistaGen Therapeutics Inc (VTGN) shares closed today at 0.7% above its 52 week low of $1.53, giving the company a market cap of $307M. The stock is currently down 21.0% year-to-date, down 32.5% over the past 12 months, and down 54.7% over the past five years. This week, the Dow Jones Industrial Average fell 3.8%, and the S&P 500 fell 3.8%.
Trading Activity
- Trading volume this week was 2.8% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | -4.9 | -21.0 | -32.5 | ||
| Dow Jones Industrial Average | -0.9 | -4.4 | 13.2 | -4.9 | 19.6 |
| S&P 500 Index | -1.1 | -5.9 | 17.9 | -5.5 | 24.9 |
| Health Care | -0.6 | -8.1 | 8.0 | -8.2 | 18.0 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 572.4%
- The company's stock price performance over the past 12 months lags the peer average by 235.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | VTGN | 0 | -21.0 | -32.5 | ||
| Peer Avg | N/A | 0 | -3.1 | -9.7 | -25.7 | 23.2 |
| Ovid Therapeutics Inc | OVID | 0 | -5.3 | 21.6 | -36.7 | 21.6 |
| Otonomy Inc | OTIC | 0 | -7.2 | -60.3 | -66.0 | 71.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: